Papers

1

Total Citations

17

H-Index

1

About

Xiaoshan Zheng is a rising leader in clinical microbiology and infectious disease diagnostics, with a focused expertise in developing rapid, automated antimicrobial susceptibility testing (AST). Their most cited work introduces the CAST-R system, a groundbreaking platform designed to deliver reliable AST results directly from positive blood cultures, addressing the critical need for speed in sepsis management. By automating the traditionally labor-intensive and time-consuming process, Zheng’s research directly combats the rise of multidrug-resistant pathogens, offering clinicians actionable data to optimize antibiotic therapy. With 17 citations on this flagship paper alone, their contributions are gaining traction among peers for their potential to transform patient outcomes. Zheng’s work stands out for its practical application in real-world clinical settings, bridging the gap between laboratory innovation and bedside decision-making. Their achievements signal a promising trajectory in precision medicine, where rapid diagnostics can save lives and curb antimicrobial resistance. For students and researchers, Zheng exemplifies how targeted technological advances can tackle pressing global health challenges.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Rapid, automated, and reliable antimicrobial susceptibility test from positive blood culture by CAST‐R
17 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Qingdao Institute of Bioenergy and Bioprocess Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago